Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

作者: Jos Jonkers , Ralph Meuwissen , Hanneke van der Gulden , Hans Peterse , Martin van der Valk

DOI: 10.1038/NG747

关键词: Wild typeBreast cancerAlleleTransgeneSuppressorBiologyLoss of heterozygosityCancer researchEpitheliumImmunologyMammary gland

摘要: … tumor-suppressor function of BRCA2, either alone or in combination with p53 loss, in several epithelial tissues including mammary-gland epithelium. We generated Brca2 F11 mice in …

参考文章(49)
Brigid Hogan, Elizabeth Lacy, Frank Costantini, Manipulating the mouse embryo: A laboratory manual ,(1986)
Mark Berneburgl, Alan R Lehmann, 3 Xeroderma pigmentosum and related disorders: Defects in DNA repair and transcription Advances in Genetics. ,vol. 43, pp. 71- 102 ,(2001) , 10.1016/S0065-2660(01)43004-5
Ralph Scully, David M. Livingston, In search of the tumour-suppressor functions of BRCA1 and BRCA2 Nature. ,vol. 408, pp. 429- 432 ,(2000) , 10.1038/35044000
B. A. J. Ponder, F. C. Thistlethwaite, A. R. Venkitaraman, W. H. Colledge, L. S. Friedman, M. J. Evans, V. P. C. C. Yu, Hyunsook Lee, K. J. Patel, K. J. Abel, M. B. L. Carlton, S. M. Hunter, Thymic Lymphomas in Mice with a Truncating Mutation in Brca2 Cancer Research. ,vol. 58, pp. 1338- 1343 ,(1998)
Nat Sternberg, Daniel Hamilton, Bacteriophage P1 site-specific recombination: I. Recombination between loxP sites Journal of Molecular Biology. ,vol. 150, pp. 467- 486 ,(1981) , 10.1016/0022-2836(81)90375-2
Philippe Soriano, Generalized lacZ expression with the ROSA26 Cre reporter strain Nature Genetics. ,vol. 21, pp. 70- 71 ,(1999) , 10.1038/5007
CA Purdie, DJ Harrison, A Peter, L Dobbie, S White, SE Howie, DM Salter, CC Bird, AH Wyllie, ML Hooper, None, Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene Oncogene. ,vol. 9, pp. 603- 609 ,(1994)
Susan J. Ramus, Lynda G. Bobrow, Paul D.P. Pharoah, Damon S. Finnigan, Ami Fishman, Marco Altaras, Patricia A. Harrington, Simon A. Gayther, Bruce A.J. Ponder, Lori S. Friedman, Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours. Genes, Chromosomes and Cancer. ,vol. 25, pp. 91- 96 ,(1999) , 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5
Joachim G. Liehr, Is estradiol a genotoxic mutagenic carcinogen Endocrine Reviews. ,vol. 21, pp. 40- 54 ,(2000) , 10.1210/EDRV.21.1.0386
Tim Crook, Louise A Brooks, Susan Crossland, P Osin, Karen T Barker, Joanne Waller, Elizabeth Philp, Paul D Smith, Isik Yulug, Julian Peto, Gillian Parker, Martin J Allday, Mark R Crompton, Barry A Gusterson, p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours Oncogene. ,vol. 17, pp. 1681- 1689 ,(1998) , 10.1038/SJ.ONC.1202106